Published in Aliment Pharmacol Ther on September 01, 2004
Utilization of surveillance colonoscopy in community practice. Gastroenterology (2009) 3.33
Utilization of upper endoscopy for surveillance of gastric ulcers in the United States. Am J Gastroenterol (2008) 2.14
Applying a natural language processing tool to electronic health records to assess performance on colonoscopy quality measures. Gastrointest Endosc (2012) 1.96
The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res (Phila) (2012) 1.48
The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterol (2006) 1.23
Influence of colonoscopy quality measures on patients' colonoscopist selection. Am J Gastroenterol (2014) 1.15
Community contextual predictors of endoscopic colorectal cancer screening in the USA: spatial multilevel regression analysis. Int J Health Geogr (2010) 1.15
Predictors of colorectal cancer screening in diverse primary care practices. BMC Health Serv Res (2006) 1.11
Predicting Colonoscopy Time: A Quality Improvement Initiative. Clin Endosc (2016) 1.10
SFRP2 methylation in fecal DNA--a marker for colorectal polyps. Int J Colorectal Dis (2007) 1.02
Non-physician performance of lower and upper endoscopy: a systematic review and meta-analysis. Endoscopy (2014) 1.00
Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening. J Oncol Pract (2012) 0.98
Colonoscopist and primary care physician supply and disparities in colorectal cancer screening. Health Serv Res (2011) 0.96
Predictors of endoscopic colorectal cancer screening over time in 11 states. Cancer Causes Control (2009) 0.93
Awareness of postpolypectomy surveillance guidelines: a nationwide survey of colonoscopists in Canada. Can J Gastroenterol (2012) 0.89
Quality and safety of screening colonoscopies performed by primary care physicians with standby specialist support. Med Care (2010) 0.89
Association of local capacity for endoscopy with individual use of colorectal cancer screening and stage at diagnosis. Cancer (2010) 0.87
Is "really conscious" sedation with solely an opioid an alternative to every day used sedation regimes for colonoscopies in a teaching hospital? Midazolam/fentanyl, propofol/alfentanil, or alfentanil only for colonoscopy: a randomized trial. Tech Coloproctol (2014) 0.84
Do colorectal cancer patients understand that their family is at risk? Dig Dis Sci (2009) 0.84
Postcolonoscopy Followup Recommendations: Comparison with and without Use of Polyp Pathology. Diagn Ther Endosc (2014) 0.83
Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy. Int J Cancer (2015) 0.81
Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer. J Immunol Methods (2013) 0.81
Surgeon-initiated screening colonoscopy program based on SAGES and ASCRS recommendations in a general surgery practice. Surg Endosc (2006) 0.80
Long-term patient satisfaction of gastrointestinal endoscopic procedures. Ann Gastroenterol (2016) 0.79
Predicting the risk of recurrent adenoma and incident colorectal cancer based on findings of the baseline colonoscopy. Clin Transl Gastroenterol (2014) 0.78
Prevalence and predictors of patient no-shows to outpatient endoscopic procedures scheduled with anesthesia. BMC Gastroenterol (2015) 0.75
How can the over-use of surveillance colonoscopy after polypectomy be modified? Dig Dis Sci (2011) 0.75
Fecal DNA-Based Detection of Colorectal Neoplasia. Curr Colorectal Cancer Rep (2007) 0.75
Hemoperitoneum as a Consequence of Colonoscopy. ACG Case Rep J (2016) 0.75
Splenic Perforation Following Colonoscopy. Gastroenterology Res (2009) 0.75
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. JAMA (1999) 9.97
Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA (2000) 7.55
Estimating hospital deaths due to medical errors: preventability is in the eye of the reviewer. JAMA (2001) 6.55
Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making (2000) 4.86
National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med (2001) 4.69
Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA (1994) 4.39
Laboratory testing on cerebrospinal fluid. A reappraisal. Lancet (1987) 4.02
Reliability and validity testing of the Michigan Hand Outcomes Questionnaire. J Hand Surg Am (1998) 3.94
A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Ann Intern Med (1993) 3.67
Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis. Ann Intern Med (2001) 3.49
"We got mail": electronic communication between physicians and patients. Am J Manag Care (1999) 3.31
Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med (2001) 2.87
What is an error? Eff Clin Pract (2001) 2.75
The measurement of active errors: methodological issues. Qual Saf Health Care (2003) 2.41
Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures. Am J Manag Care (2001) 2.36
Electron-beam computed tomography in the diagnosis of coronary artery disease: a meta-analysis. Arch Intern Med (2001) 2.28
Who bounces back? Physiologic and other predictors of intensive care unit readmission. Crit Care Med (2001) 2.25
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23
Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med (1997) 2.22
A national study of the quantity and cost of informal caregiving for the elderly with stroke. Neurology (2002) 2.20
Identifying poor-quality hospitals. Can hospital mortality rates detect quality problems for medical diagnoses? Med Care (1996) 2.14
The Michigan Hand Outcomes Questionnaire (MHQ): assessment of responsiveness to clinical change. Ann Plast Surg (1999) 2.04
Variation in organ quality between liver transplant centers. Am J Transplant (2011) 1.99
Estimating the cost of informal caregiving for elderly patients with cancer. J Clin Oncol (2001) 1.92
Managed care, medical technology, and health care cost growth: a review of the evidence. Med Care Res Rev (1998) 1.72
Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med (2000) 1.71
The role of hospital volume in coronary artery bypass grafting: is more always better? J Am Coll Cardiol (2001) 1.68
Research evidence on the validity of risk-adjusted mortality rate as a measure of hospital quality of care. Med Care Res Rev (1998) 1.67
Breast cancer screening in the United States and Canada, 1994: socioeconomic gradients persist. Am J Public Health (2000) 1.66
Discussion between reviewers does not improve reliability of peer review of hospital quality. Med Care (2000) 1.65
Access to medical care for children and adolescents in the United States. Pediatrics (1990) 1.64
Report of the health care delivery work group: behavioral research related to the establishment of a chronic disease model for diabetes care. Diabetes Care (2001) 1.61
Decomposing pharmaceutical cost growth in different types of health plans. Am J Manag Care (2001) 1.57
Automated computerized intensive care unit severity of illness measure in the Department of Veterans Affairs: preliminary results. SISVistA Investigators. Scrutiny of ICU Severity Veterans Health Sysyems Technology Architecture. Crit Care Med (2000) 1.56
Cardiologists performing peripheral angioplasties: impact on utilization. Eff Clin Pract (2001) 1.56
Department of Veterans Affairs' Quality Enhancement Research Initiative for Diabetes Mellitus. Med Care (2000) 1.53
Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. Arch Intern Med (1992) 1.49
Barriers to following dietary recommendations in Type 2 diabetes. Diabet Med (2005) 1.49
The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med (2000) 1.48
Helicobacter pylori--more light, less heat. Am J Gastroenterol (1998) 1.46
Accuracy of risk-adjusted mortality rate as a measure of hospital quality of care. Med Care (1999) 1.43
The acquired immunodeficiency syndrome is a primary care disease. Ann Intern Med (1988) 1.40
Toward a national hepatitis B vaccination program. Hosp Pract (Off Ed) (1994) 1.39
Practical advice on eradicating Helicobacter pylori infection. Postgrad Med (1999) 1.38
Helicobacter pylori-related disease: guidelines for testing and treatment. Arch Intern Med (2000) 1.38
Physician use in Ontario and the United States: The impact of socioeconomic status and health status. Am J Public Health (1996) 1.34
Do the criteria of resident selection committees predict residents' performances? Acad Med (1995) 1.31
As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia. Aliment Pharmacol Ther (2008) 1.25
Patients' desires and expectations for medical care in primary care clinics. J Gen Intern Med (1998) 1.23
Initial emergency department diagnosis and return visits: risk versus perception. Ann Emerg Med (1998) 1.23
Health plan report cards: exploring differences in plan ratings. Jt Comm J Qual Improv (1998) 1.21
Specialist and generalist physicians' adoption of antibiotic therapy to eradicate Helicobacter pylori infection. Med Care (1996) 1.15
Respiratory illness caused by picornavirus infection: a review of clinical outcomes. Clin Ther (2001) 1.11
Out-of-pocket payments and use of care for serious and minor symptoms. Results of a national survey. Arch Intern Med (1989) 1.11
APACHE-L: a new severity of illness adjuster for inpatient medical care. Med Care (1992) 1.08
Where health and welfare meet: social deprivation among patients in the emergency department. J Urban Health (2001) 1.05
Are randomized controlled trials sufficient evidence to guide clinical practice in type II (non-insulin-dependent) diabetes mellitus? Diabetologia (2000) 1.04
Measuring physician attitudes toward cost, uncertainty, malpractice, and utilization review. J Gen Intern Med (1994) 1.03
Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2006) 1.02
Comparing the hospitalizations of transfer and non-transfer patients in an academic medical center. Acad Med (1996) 1.00
Can early re-admission rates accurately detect poor-quality hospitals? Med Care (1995) 0.98
The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists. Ophthalmology (1999) 0.95
Scope and consequences of peptic ulcer disease. How important is asymptomatic Helicobacter pylori infection? Postgrad Med (1999) 0.95
Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis. Aliment Pharmacol Ther (2002) 0.95
The costs of cancer to a major employer in the United States: a case-control analysis. Am J Manag Care (2000) 0.93
Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review. Diabet Med (2013) 0.91
Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice. Arch Intern Med (2001) 0.91
Residents' experiences in, and attitudes toward, the care of persons with AIDS in Canada, France, and the United States. JAMA (1992) 0.90
Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies. Pharmacoeconomics (2001) 0.90
Effects of horizontal whole-body vibration on reading. Appl Ergon (1994) 0.90
Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention. Aliment Pharmacol Ther (2011) 0.89
Measuring health-related quality of life in patients with upper gastrointestinal disease. Dig Dis (1999) 0.89
The tension between cost containment and the underutilization of effective health services. Int J Technol Assess Health Care (1996) 0.87
The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines. Arch Intern Med (1996) 0.87
Measures of vibrotactile sensitivity in persons exposed to hand-arm vibration. Scand J Work Environ Health (1986) 0.87
Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia. Am J Gastroenterol (2001) 0.87
Hospital utilization in Ontario and the United States: the impact of socioeconomic status and health status. Can J Public Health (1996) 0.86
The integrated inpatient management model's clinical management information system. Hosp Health Serv Adm (1994) 0.85
Validating quality indicators for hospital care. Jt Comm J Qual Improv (1997) 0.85
Diagnostic testing for influenza: review of current status and implications of newer treatment options. Am J Manag Care (1999) 0.85
A method for counting ectopic beats by computer analysis of R-R intervals. Eur J Cardiol (1977) 0.85
Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia. Mayo Clin Proc (2000) 0.85
Patients' desires and expectations for medical care: a challenge to improving patient satisfaction. Am J Med Qual (1999) 0.85
Managed care and medical technology: implications for cost growth. Health Aff (Millwood) (1997) 0.85
Gastroenterologists utilize the referral for EGD to enhance colon cancer screening more effectively than primary care physicians. Aliment Pharmacol Ther (2006) 0.85
Choosing between apples and apples: physicians' choices of prescription drugs that have similar side effects and efficacies. J Gen Intern Med (1992) 0.84
Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon. Angiology (1989) 0.84
The benefits of, controversies surrounding, and professional recommendations for routine PSA testing: what do men believe? Am J Med (2001) 0.83
The integrated inpatient management model. Lessons for managed care. Med Care (1995) 0.83
Helicobacter pylori screening for individuals requiring chronic NSAID therapy: a decision analysis. Aliment Pharmacol Ther (2001) 0.83
The dynamics of innovation in minimally invasive therapy. Health Policy (1993) 0.82
Knowledge of blood pressure targets among patients with diabetes. Prim Care Diabetes (2007) 0.82